Insider Transactions in Q3 2022 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2022
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-6.45%
|
$6,193
$11.44 P/Share
|
|
Sep 02
2022
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
995
+10.23%
|
-
|
|
Sep 02
2022
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-7.93%
|
$21,219
$11.44 P/Share
|
|
Sep 02
2022
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,569
+21.26%
|
-
|
|
Sep 02
2022
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-1.38%
|
$5,577
$11.44 P/Share
|
|
Sep 02
2022
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,725
+4.47%
|
-
|
|
Sep 02
2022
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
547
-6.66%
|
$6,017
$11.44 P/Share
|
|
Sep 02
2022
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,861
+18.46%
|
-
|
|
Sep 02
2022
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-0.5%
|
$6,347
$11.44 P/Share
|
|
Sep 02
2022
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+1.68%
|
-
|
|
Sep 02
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-3.03%
|
$2,508
$11.44 P/Share
|
|
Sep 02
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
775
+9.34%
|
-
|
|
Jul 15
2022
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
360
+4.45%
|
$3,240
$9.56 P/Share
|
|
Jul 15
2022
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,048
+0.92%
|
$9,432
$9.56 P/Share
|
|
Jul 15
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
703
+9.44%
|
$6,327
$9.56 P/Share
|